Insight into tumour marker development
The growth of molecular genetic technologies has enabled advances in personalized medicine, particularly in the field of cancer diagnosis, prognosis and therapeutic decision-making. CLI caught up with Dr Jennifer Keynton (Diagnostics R&D Manager at Horizon Discovery) to find out more about the development of tumour markers and the role of reference standards in cancer diagnostics […]